Besides, it is potentially that CmyB might also be one of the influencing factors of ECV in diseased individuals, especially patients with altered sizes of cardiomyocytes, such as hypertrophic cardiomyopathy and Anderson-Fabry disease (49, 50), which is currently unclear and needs to be confirmed by further research. This evidence concerns the gene MYB and hypertrophic cardiomyopathy.